Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Infliximab

5

XVII.g Tuberculosis (pulmonary, pulmonary, extrapulmonary or disseminated). Reactivation or de novo

5
Last update : 14/01/2014
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Biosimilars
1
Infliximab biosimilar
1
TNF-alpha antagonists / inhibitors
5

Publications

Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: disseminated infection after treatment with infliximab.
Journal of Crohn's & colitis 2014 Jun;8;560-2 2014 Jun
Development of miliary tuberculosis under infliximab in a patient with spondyloarthritis and suspected Crohn's disease.
Zeitschrift fur Gastroenterologie 2013 Oct;51;1177-83 2013 Oct
Intestinal tuberculosis mimicking Crohn disease in infliximab-treated rheumatoid arthritis.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2012 Sep;18;324 2012 Sep
Disseminated tuberculosis in a Crohn's disease patient on anti-TNF alpha therapy despite chemoprophylaxis.
Gut 2008 Mar;57;425; author reply 425-6 2008 Mar
Pulmonary nodules in an infliximab-treated rheumatoid arthritis patient: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery.
HSS journal : the musculoskeletal journal of Hospital for Special Surgery 2007 Feb;3;119-25 2007 Feb
Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis.
Internal medicine (Tokyo, Japan) 2006;45;685-8 2006
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy.
Arthritis and rheumatism 2004 Feb;50;372-9 2004 Feb
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
Arthritis and rheumatism 2003 Aug;48;2122-7 2003 Aug
Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment.
Scandinavian journal of rheumatology 2002;31;44-5 2002

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies